- Home
- CTOR vs MLSS Comparison
CTOR vs MLSS Comparison
Compare CTOR & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOR
- MLSS
- Stock Information
- Founded
- CTOR 2021
- MLSS 1989
- Country
- CTOR United States
- MLSS United States
- Employees
- CTOR N/A
- MLSS N/A
- Industry
- CTOR
- MLSS Industrial Specialties
- Sector
- CTOR
- MLSS Health Care
- Exchange
- CTOR NYSE
- MLSS Nasdaq
- Market Cap
- CTOR 63.7M
- MLSS 74.9M
- IPO Year
- CTOR N/A
- MLSS 1995
- Fundamental
- Price
- CTOR $5.05
- MLSS $0.73
- Analyst Decision
- CTOR Buy
- MLSS Buy
- Analyst Count
- CTOR 2
- MLSS 1
- Target Price
- CTOR $6.00
- MLSS $1.25
- AVG Volume (30 Days)
- CTOR 3.1M
- MLSS 87.7K
- Earning Date
- CTOR 08-11-2025
- MLSS 08-13-2025
- Dividend Yield
- CTOR N/A
- MLSS N/A
- EPS Growth
- CTOR N/A
- MLSS N/A
- EPS
- CTOR N/A
- MLSS N/A
- Revenue
- CTOR N/A
- MLSS $8,613,503.00
- Revenue This Year
- CTOR N/A
- MLSS $29.14
- Revenue Next Year
- CTOR N/A
- MLSS $20.19
- P/E Ratio
- CTOR N/A
- MLSS N/A
- Revenue Growth
- CTOR N/A
- MLSS N/A
- 52 Week Low
- CTOR $0.55
- MLSS $0.57
- 52 Week High
- CTOR $49.00
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- CTOR N/A
- MLSS 26.30
- Support Level
- CTOR N/A
- MLSS $0.73
- Resistance Level
- CTOR N/A
- MLSS $0.92
- Average True Range (ATR)
- CTOR 0.00
- MLSS 0.05
- MACD
- CTOR 0.00
- MLSS -0.02
- Stochastic Oscillator
- CTOR 0.00
- MLSS 9.58
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.